Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy. | Oncotarget | 2022 | 36128328 | PubTator, text mining | PubMed |
| Hereditary Leiomyomatosis and Renal Cell Cancer-Recognizing Patterns May Save Lives. | J Kidney Cancer VHL | 2022 | 36118792 | PubTator, text mining | PubMed |
| TGF-β signaling in the tumor metabolic microenvironment and targeted therapies. | J Hematol Oncol | 2022 | 36115986 | PubTator, text mining | PubMed |
| Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective. | Signal Transduct Target Ther | 2022 | 36115852 | PubTator, text mining | PubMed |
| Gankyrin and TIGAR cooperatively accelerate glucose metabolism toward the PPP and TCA cycle in hepatocellular carcinoma. | Cancer Sci | 2022 | 36114745 | PubTator, text mining | PubMed |
| Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets. | Transl Oncol | 2022 | 36113343 | PubTator, text mining | PubMed |
| Targeting OXPHOS de novo purine synthesis as the nexus of FLT3 inhibitor-mediated synergistic antileukemic actions. | Sci Adv | 2022 | 36112677 | PubTator, text mining | PubMed |
| A novel case of hereditary leiomyomatosis- associated renal cell carcinoma with metastasis to pituitary gland. | Urol Case Rep | 2022 | 36105545 | PubTator, text mining | PubMed |
| Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. | J Exp Clin Cancer Res | 2022 | 36089608 | PubTator, text mining | PubMed |
| Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells. | Int J Mol Sci | 2022 | 36077431 | PubTator, text mining | PubMed |
| Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma. | Clin Cancer Res | 2022 | 36074152 | PubTator, text mining | PubMed |
Quantitative proteome profiling reveals molecular hallmarks of egg quality in Atlantic halibut: impairments of transcription and protein folding impede protein and energy homeostasis during early development. | BMC Genomics | 2022 | 36071374 | PubTator, text mining | PubMed |
| What's new in kidney tumor pathology 2022: WHO 5th edition updates. | J Pathol Transl Med | 2022 | 36069072 | PubTator, text mining | PubMed |
| A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase. | Oncogenesis | 2022 | 36068196 | PubTator, text mining | PubMed |
| Family History of Cancers Increases Risk of Renal Cell Carcinoma in a Chinese Population. | Cancer Manag Res | 2022 | 36065260 | PubTator, text mining | PubMed |
| C4-dicarboxylate metabolons: interaction of C4-dicarboxylate transporters of Escherichia coli with cytosolic enzymes. | FEMS Microbiol Lett | 2022 | 36044995 | PubTator, text mining | PubMed |
| Impact of a bisphenol A, F, and S mixture and maternal care on the brain transcriptome of rat dams and pups. | Neurotoxicology | 2022 | 36041667 | PubTator, text mining | PubMed |
| The pathway for coenzyme M biosynthesis in bacteria. | Proc Natl Acad Sci U S A | 2022 | 36037354 | PubTator, text mining | PubMed |
| Identification and Validation of TRIM25 as a Glucose Metabolism Regulator in Prostate Cancer. | Int J Mol Sci | 2022 | 36012594 | PubTator, text mining | PubMed |
| The Chromatin Remodeler HELLS: A New Regulator in DNA Repair, Genome Maintenance, and Cancer. | Int J Mol Sci | 2022 | 36012581 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=33